Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportOncology: Basic, Translational & Therapy

In vivo enrichment of cancer stem cells in histone deacetylase inhibitor resistant xenograft of lung cancer in mouse model

Wei-Ying Kuo, Luen Hwu, Chun-Yi Wu, Hsin-Ell Wang and Ren-Shyan Liu
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 546;
Wei-Ying Kuo
1Dept of Nuclear Medicine, Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luen Hwu
2NPCC, Taipei Veterans General Hospital, Taipei, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chun-Yi Wu
1Dept of Nuclear Medicine, Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hsin-Ell Wang
1Dept of Nuclear Medicine, Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ren-Shyan Liu
2NPCC, Taipei Veterans General Hospital, Taipei, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

546

Objectives Cancer stem cells (CSCs) are usually resistant to chemotherapy and radiotherapy and responsible for tumor relapse. Although CSCs can be generated in vitro by non-adherent suspension culture in serum-free medium, the biologic characteristic of tumorspheres was far from CSCs in real tumors due to the distinct environmental factors, such as stroma cells, inflammation and hypoxia within tumor, which may profoundly reprogram CSCs. Histone deacetylase inhibitors (HDACIs) may induce epithelial-to-mesenchymal transition (EMT) and CSC-enriched characteristics during treatment. This study aimed to develop an in vivo CSCs-screening system using suberoylanilide hydroxamic acid (SAHA) to enrich the CSC population to facilitate the isolation of CSCs from solid tumors.

Methods We established a H1299 cell clone (NSCLC) which stably expressed a triple-fused reporter gene (DsRedm-Fluc-tTKsr39) under the control of CMV promoter. Tumor cells were tracked by in vivo luminescence imaging after continuous SAHA treatment of tumor-bearing mice. Using the Aldefluor assay, viable CSCs were isolated from xenograft tumors which co-express the reporter gene and ALDH activity. The stem cell phenotype of CSCs was assessed by a cell invasion assay, analyzing CSC-related gene expression, and immunohistochemical staining for ALDH1A1 in vitro.

Results Tumor tissues from SAHA-treated mice had increased CSC population which is enriched by continuous administration of SAHA (4.14% vs 1.50% of control). The microarray analysis showed that genes involved in the maintenance of CSCs, self-renewal and metastasis were upregulated in these isolated CSCs. In addition, the invasive ability of these SAHA-induced CSCs was also significantly elevated.

Conclusions We isolated and characterized CSCs by using in vivo reporter gene imaging and Aldefluor assay. These results may improve understanding of the molecular mechanism of CSCs and facilitate the discovery of specific targets of CSCs.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 55, Issue supplement 1
May 2014
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
In vivo enrichment of cancer stem cells in histone deacetylase inhibitor resistant xenograft of lung cancer in mouse model
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
In vivo enrichment of cancer stem cells in histone deacetylase inhibitor resistant xenograft of lung cancer in mouse model
Wei-Ying Kuo, Luen Hwu, Chun-Yi Wu, Hsin-Ell Wang, Ren-Shyan Liu
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 546;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
In vivo enrichment of cancer stem cells in histone deacetylase inhibitor resistant xenograft of lung cancer in mouse model
Wei-Ying Kuo, Luen Hwu, Chun-Yi Wu, Hsin-Ell Wang, Ren-Shyan Liu
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 546;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Basic, Translational & Therapy

  • Investigation of volume-of-interest (VOI) definition methods for estimating organ activity concentrations in quantitative SPECT (QSPECT)
  • 188Re-microspheres for selective intra-arterial radionuclide therapy (SIRT) in patients with HCC: Feasibility study
  • SUVmax of Normal Tissues in Pediatric and Adult Patients on FDG PET/MR
Show more Oncology: Basic, Translational & Therapy

Breast and Lung Cancer

  • Limitations of [18F]fluorothymidine as a proliferation biomarker in a preclinical model of breast cancer: Role of sex-dependent differences in tissue biodistribution
  • Development of a HER3 PET probe for breast cancer imaging
Show more Breast and Lung Cancer

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire